Kereos, Inc.

4041 Forest Park Ave.
Saint Louis
Missouri, 63108
United States
PH: +01 (314) 633-1879
Visit Kereos, Inc. Website or Request Quote for Further Information

Company Background

Kereos, Inc. develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease earlier and more specifically than currently possible. The specificity and unique capabilities of Kereos' molecular imaging agents enable earlier and more definitive diagnosis of disease. Similarly, Kereos' targeted therapeutics seek out definitive disease biomarkers and carry powerful payloads of proven chemotherapeutics, making them potentially more effective and less toxic in treating disease.